LANTERN PHARMA INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.52 USD | -3.21% |
|
+15.60% | +5.61% |
Chart calendar Lantern Pharma Inc.
5.YDOoPZFhokzPk07tum1H3mAqHZDTNWdO-4nKfx2L8n0.N1LpWucpxhat-iiu7BU2pDFTReirYlB-zuSuK03UmjomHutp_QrnHqrlAw~1e78bbe3f9ab8ba0df6f917641abab9c
Upcoming events on Lantern Pharma Inc.
Past events on Lantern Pharma Inc.
| 13/06/2024 08:30 pm | Annual General Meeting |
| 29/05/2024 10:30 pm | Investor Meeting - Key Opinion Leaders |
| 10/05/2024 02:00 am | Q1 2024 Earnings Call |
| 10/05/2024 01:32 am | Q1 2024 Earnings Release |
| 20/03/2024 | Rare Disease Summit |
| 19/03/2024 02:00 am | Q4 2023 Earnings Call |
| 19/03/2024 01:32 am | Q4 2023 Earnings Release |
| 08/03/2024 12:30 am | H.C. Wainwright Artificial Intelligence Based Drug Discovery & Development Virtual Conference - Fire |
| 06/12/2023 12:00 am | CNS Drug Delivery Summit |
| 01/12/2023 12:00 pm | Bengaluru Tech Summit |
| 18/11/2023 12:25 am | Society for Neuro Oncology Meeting |
| 09/11/2023 03:00 am | Q3 2023 Earnings Call |
| 09/11/2023 02:31 am | Q3 2023 Earnings Release |
| 19/10/2023 11:00 pm | ThinkEquity Conference |
| 07/09/2023 04:30 am | Society of Hematologic Oncology Meeting - Poster Number: ABCL-180 |
| 24/08/2023 01:15 pm | Drug Conjugates for Directed Therapy International Conference |
| 11/08/2023 06:00 am | American Society of Clinical Oncology CNS Cancer Conference |
| 10/08/2023 02:00 am | Q2 2023 Earnings Call |
| 10/08/2023 01:31 am | Q2 2023 Earnings Release |
| 23/07/2023 | Cancer Molecular Therapeutics Research Association Conference |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | -12,6 -13,3 5.38% | -13,2 -14,5 8.72% | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -5,91 -5,84 -1.13% | -12,6 -13,6 7.73% | -14,4 -16,1 10.52% | -17,9 -17,8 -0.49% | -24,6 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -5,91 -5,81 -1.66% | -12,4 -13,2 6.24% | -14,3 -16,3 12.42% | -16,0 -16,1 1% | -24,0 |
|
Net income Million USD | Released Forecast Spread | -5,91 -5,81 -1.66% | -12,4 -13,2 6.24% | -14,3 -16,2 12.01% | -16,0 -16,4 2.96% | -24,0 |
|
EPS USD | Released Forecast Spread | -1,37 -1,35 -1.48% | -1,13 -1,21 6.22% | -1,31 -1,48 11.49% | -1,47 -1,51 2.43% | -2,23 |
| Announcement Date | 10/03/21 | 10/03/22 | 20/03/23 | 18/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -4,06 -3,60 -12.9% | -1,84 -4,40 58.15% | -3,49 -4,70 25.67% | -3,95 -5,00 21.01% | -4,79 -5,30 9.54% | |||||||
|
EBIT Million USD | Released Forecast Spread | -4,07 -3,60 -12.96% | -4,39 -5,65 22.17% | -2,15 -5,30 59.53% | -3,83 -5,19 26.29% | -4,29 -5,30 19.13% | -5,19 -4,91 -5.69% | -3,52 -5,15 31.51% | -4,88 -4,63 -5.24% | -5,73 -5,40 -6.15% | -6,09 | -6,28 | -6,50 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -4,12 -3,20 -28.81% | -4,49 -5,63 20.19% | -2,26 -5,24 56.81% | -3,38 -5,14 34.16% | -3,87 -5,20 25.62% | -4,75 -4,74 -0.19% | -3,16 -4,94 35.94% | -4,19 -4,33 3.43% | -5,44 -4,70 -15.76% | -5,94 | -6,18 | -6,45 |
|
Net income Million USD | Released Forecast Spread | -4,12 -3,20 -28.81% | -4,49 -5,63 20.19% | -2,26 -5,24 56.81% | -3,38 -5,14 34.16% | -3,87 -5,20 25.62% | -4,75 -4,74 -0.19% | -3,16 -4,94 35.94% | -4,19 -4,33 3.43% | -5,44 -4,70 -15.76% | -5,94 | -6,18 | -6,45 |
|
EPS USD | Released Forecast Spread | -0,38 -0,29 -31.03% | -0,41 -0,52 21.15% | -0,21 -0,48 56.25% | -0,31 -0,47 34.04% | -0,36 -0,48 25% | -0,44 -0,43 -1.54% | -0,29 -0,46 36.26% | -0,38 -0,40 5% | -0,51 -0,43 -18.6% | -0,55 | -0,57 | -0,60 |
| Announcement Date | 03/05/22 | 08/08/22 | 07/11/22 | 20/03/23 | 09/05/23 | 09/08/23 | 08/11/23 | 18/03/24 | 09/05/24 | - | - | - |
| 15/07/2024 11:15 am | ADDLIFE AB: Q2 2024 Earnings Release |
| 22/07/2024 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release |
| 24/07/2024 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release |
| 24/07/2024 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
| 24/07/2024 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
| 24/07/2024 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
| 25/07/2024 | LONZA GROUP AG: Q2 2024 Earnings Release |
| 25/07/2024 10:30 am | BACHEM HOLDING AG: Q2 2024 Earnings Release |
| 26/07/2024 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
| 26/07/2024 10:30 am | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for Lantern Pharma Inc.
| 07/06/2024 12:27 pm | POLARIS GROUP: May 2024 Sales and Revenue Release |
| 30/05/2024 01:31 am | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
| 23/05/2024 04:30 pm | CUREVAC N.V.: Q1 2024 Earnings Release |
| 22/05/2024 10:30 am | EVOTEC SE: Q1 2024 Earnings Release |
| 22/05/2024 02:44 am | ALVOTECH: Q1 2024 Earnings Release |
| 21/05/2024 04:30 pm | EXSCIENTIA PLC: Q1 2024 Earnings Release |
| 17/05/2024 11:30 am | BIOARCTIC AB: Q1 2024 Earnings Release |
| 16/05/2024 01:35 am | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 15/05/2024 04:30 pm | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 15/05/2024 | GNI GROUP LTD.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- LTRN Stock
- Calendar Lantern Pharma Inc.
